Please login to the form below
ENVI
This page shows the latest ENVI news and features for those working in and with pharma, biotech and healthcare.
EU group calls for 'targeted actions' to mitigate impact of Brexit
The Committee on the Environment, Public Health and Food Safety (ENVI) published its take on the exit agreement on Tuesday. ... As ENVI sees it, such mutual recognition is needed to ensure patient safety.
Latest news
-
Ursula von der Leyen nominated for EU President role
the ENVI committee. ... The Greens won a great number of seats and will look to secure high profile jobs at the ENVI committee, and are well known for their distrust of the pharma sector.
-
Industry welcomes European diagnostics regulations
Trade bodies say they will support greater use of personalised medicines
-
MEPs agree clinical trial regulation revision
The regulation is now forwarded to the Environment, Public Health and Food Safety (ENVI) committee for technical finalisation and approval, after which it will be voted on in the entire Parliament.
-
Telling times for medical devices in EU
Following a vote by the European Parliament's Environment, Public Health and Food Safety (ENVI) Committee on September 25, if you are a manufacturer who produces 'high-risk' products, you will
-
EMA commits to disclosure of data from trials
The shift to greater openness seems inevitable in the wake of the recent European Parliament Environment, Public Health and Food Safety (ENVI) committee vote to amend the Clinical Trial Directive (CTD), ... The EMA also noted that the ongoing legislative
More from news
Approximately 1 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
A new EU in the making, what lies ahead for pharma?
The Greens won a great number of seats and will play on this result to secure high profile jobs at the ENVI committee which is in charge of Environment, Public Health
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn
- Landscape review reveals £1.1bn of UK funding for rare diseases
- Cancer Research UK partners with French cancer institute
- New diagnosis pathway has been launched to mark European Myeloma Day
- Impacting Lives with Rare Disease Education
- Sandoz biosimilar receives EC approval to treat MS
No results were found
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
